Michael G. Miskelly

Malmoe, M 21428, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

HMGCR and Rosuvastatin Regulates GLP-1 Secretion and Expression-A Translational Study.

HMGCR and Rosuvastatin Regulates GLP-1 Secretion and Expression-A Translational Study.

Journal: The Journal of clinical endocrinology and metabolism

Published: June 24, 2025

HMGCR and rosuvastatin regulates GLP-1 secretion and expression - a translational study.

HMGCR and rosuvastatin regulates GLP-1 secretion and expression - a translational study.

Journal: The Journal of clinical endocrinology and metabolism

Published: June 24, 2025

The Effects of Calorie Restriction and Bariatric Surgery on Circulating Proneurotensin Levels.

The Effects of Calorie Restriction and Bariatric Surgery on Circulating Proneurotensin Levels.

Journal: The Journal of clinical endocrinology and metabolism

Published: December 13, 2023

RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine.

RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine.

Journal: Diabetologia

Published: May 22, 2023

Metabolic remission precedes possible weight regain after gastric bypass surgery.

Metabolic remission precedes possible weight regain after gastric bypass surgery.

Journal: Obesity (Silver Spring, Md.)

Published: March 09, 2023

Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice.

Antidiabetic actions of GPR55 agonist Abn-CBD and sitagliptin in obese-diabetic high fat fed mice.

Journal: Biochemical pharmacology

Published: November 09, 2022

Incretins play an important role in FFA4/GPR120 regulation of glucose metabolism by GW-9508.

Incretins play an important role in FFA4/GPR120 regulation of glucose metabolism by GW-9508.

Journal: Life sciences

Published: October 14, 2022

In vivo drug discovery for increasing incretin-expressing cells identifies DYRK inhibitors that reinforce the enteroendocrine system.

In vivo drug discovery for increasing incretin-expressing cells identifies DYRK inhibitors that reinforce the enteroendocrine system.

Journal: Cell chemical biology

Published: October 27, 2021

GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.

GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.

Journal: Peptides

Published: June 26, 2020

Ghrelin suppresses insulin secretion in human islets and type 2 diabetes patients have diminished islet ghrelin cell number and lower plasma ghrelin levels.

Ghrelin suppresses insulin secretion in human islets and type 2 diabetes patients have diminished islet ghrelin cell number and lower plasma ghrelin levels.

Journal: Molecular and cellular endocrinology

Published: February 12, 2020

CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function.

CRISPR/Cas9 gene editing demonstrates metabolic importance of GPR55 in the modulation of GIP release and pancreatic beta cell function.

Journal: Peptides

Published: October 11, 2019

Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis.

Pharmacological potential of novel agonists for FFAR4 on islet and enteroendocrine cell function and glucose homeostasis.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: February 22, 2019

Showing 1-12 of 13

Last Updated: 09/26/2026